Chandigarh Today

Dear Friends, Chandigarh Today launches new logo animation for its web identity. Please view, LIKE and share. Best Regards http://chandigarhtoday.org

Posted by Surinder Verma on Tuesday, June 23, 2020

PRESS RELEASE:Another Feather in the Cap of PGIMER

0
100

PRESS RELEASE

Another Feather in the Cap of PGIMER
Dr Ritesh Agarwal awarded the prestigious Shanti Swaroop Bhatnagar Prize for 2020
The Ist Faculty to be awarded with this distinct honor

Chandigarh: 26th September: Dr Ritesh Agarwal , Professor in Deptt of Pulmonary Medicine, PGIMER,
has been awarded the prestigious Shanti Swarup Bhatnagar Prize for Science and Technology for the year 2020 in the medical sciences category, for his significant contributions in the field of allergic bronchopulmonary aspergillosis (ABPA).

The award is named after the founder Director of the Council of Scientific & Industrial Research (CSIR) India, the late Dr (Sir) Shanti Swarup Bhatnagar. The Prize is given each year for outstanding contributions in science and technology.

Dr Agarwal is the first faculty from the PGI, Chandigarh to be honored with this award.

Commending Prof. Agarwal’s distinct accomplishment, Prof Jagat Ram, Director PGIMER stated, ” It is a matter of great pride not only for the institute but also for the region. This rare honor won by Prof. Agarwal is hugely motivational and exemplary for others to follow his footsteps.”

Prof. Agarwal has been systematically exploring this perplexing disease over the last ten years and has more than 90 publications describing the epidemiology, diagnosis, management, and several first-time descriptions. In the last five years, he has validated several existing diagnostic and classification criteria and has proposed new criteria for the diagnosis and classification of ABPA, which are used to diagnose ABPA worldover. The most significant work of Dr. Agarwal is in the treatment of ABPA. Before his research, there was no dosing protocol for oral glucocorticoids. His research has shown that lower doses of oral steroids are sufficient in the treatment of ABPA. Moreover, two of his studies demonstrating the efficacy of antifungal drugs are practice-changing, as patients can now be spared of the serious adverse effects of glucocorticoids.

Dr Agarwal has more than 500 publications in peer-reviewed National and International Journals. He has also received the ICMR Kamal Satbir Award for the year 2009, and the NASI-Scopus young scientist award for the year 2011, and the ICMR Shakuntala Amir Chand Award for the year 2012, for his dedicated work in the field of allergic bronchopulmonary aspergillosis.

Thanks & Regards 
Public Relations Office,
PGIMER, Chandigarh.
pro9pgimer@gmail.com
Contact : 7087008001; 9779560572; 0172- 2756003